Abstract
Somatic frameshift mutations in some genes containing coding mononucleotide repeats (cMNRs) are well known characteristics of tumors with high microsatellite instability (MSI-H). We identified 22 novel and 11 known target genes containing cMNRs with a length of 10 or more nucleotides by using a systematic database search. Frameshift mutation analysis was performed with these 33 genes in 39 MSI-H and 24 microsatellite stable (MSS) colorectal carcinomas by assessing the mobility shifts of PCR products in gel electrophoresis and by sequencing. All the 39 MSI-H colorectal carcinomas, except one, showed mutations in more than one gene, while no mutations were found in 24 MSS colorectal carcinomas. Of these MSI-H tumors, 11 genes were mutated in more than 40%. The most frequently mutated novel genes were MARCKS (72%), FLJ11383 (74%) and TAF1B (82%). Biallelic inactivation in MARCKS and FLJ11383 was also frequent in MSI-H tumors. The observed mutation frequency of the 11 known target genes was compatible with that found by previous studies. The very high frequency of mutations, biallelic mutations and the predicted truncation of protein products suggests that mutations of MARCKS, FLJ11383 and TAF1B are selected, and play a role in the tumorigenesis of MSI-H colorectal carcinomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bader S, Walker M, Hendrich B, Bird A, Bird C, Hooper M, Wyllie A . 1999 Oncogene 18: 8044–8047
Blackshear PJ . 1993 J. Biol. Chem. 268: 1501–1504
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava SA . 1998 Cancer Res. 58: 5248–5257
Brooks G, Brooks SF, Gross MW . 1996 Carcinogenesis 17: 683–689
Brooks SF, Herget T, Broad S, Rozengurt E . 1992 J. Biol. Chem. 267: 14212–14218
Chen J, Heerdt BG, Augenlicht LH . 1995 Cancer Res. 55: 174–180
Choi SJ, Kim SK, Kim SJ, Koh CM, Park YS . 1998 J. Korean Cancer Assoc. 30: 527–535
Comai L, Zomerdijk JCBM, Beckmann H, Zhou S, Admon A, Tjian R . 1994 Science 266: 1966–1972
Duval A, Iacopetta B, Ranzani GN, Lothe RA, Thomas G, Hamelin R . 1999 Oncogene 18: 6806–6809
Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, Thibodeau SN, Richards CS, Ward PA, Nelson DL . 1994 Nat. Genet. 8: 88–94
Eshleman JR, Markowitz SD . 1996 Hum. Mol. Genet. 5: 1489–1494
Herget T, Brooks SF, Broad S, Rozengurt E . 1993 Proc. Natl. Acad. Sci. USA 90: 2945–2949
Kim JJ, Baek MJ, Kim L, Kim NG, Lee YC, Song SY, Noh SH, Kim H . 1999 Lab. Invest. 79: 1113–1120
Kim NG, Choi YR, Baek MJ, Kim YH, Kang H, Kim NK, Min JS, Kim H . 2001 Cancer Res. 61: 36–38
Ku JL, Yoon KA, Kim DY, Park JG . 1999 Eur. J. Cancer 35: 1724–1729
Lengauer C, Kinzler KW, Vogelstein B . 1997 Proc. Natl. Acad. Sci. USA 94: 2545–2550
Malkhosyan S, Rampino N, Yamamoto H, Perucho M . 1996 Nature 382: 499–500
Manenti S, Malecaze F, Chap H, Darbon JM . 1998 Cancer Res. 58: 1429–1434
Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV . 1995 Science 268: 1336–1338
Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ, Stein OC . 2001 Cancer Res. 61: 6046–6049
Ohmiya N, Matsumoto S, Yamamoto H, Baranovskaya S, Malkhosyan SR, Perucho M . 2001 Gene 272: 301–313
Park J, Betel D, Gryfe R, Michalickova K, Di Nicola N, Gallinger S, Hogue CW, Redston M . 2002 Cancer Res. 62: 1284–1288
Park JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE, Gazdar A . 1987 Cancer Res. 47: 6710–6718
Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5548–5550
Perucho M . 1996 Biol. Chem. 377: 675–684
Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M . 1997 Science 275: 967–969
Schwartz Jr S, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M . 1999 Cancer Res. 59: 2995–3002
Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YO, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ . 1996 Nat. Genet. 14: 255–257
Strand M, Prolla TA, Liskay RM, Petes TD . 1993 Nature 365: 274–276
Tran HT, Keen JD, Kricker M, Resnick MA, Gordenin DA . 1997 Mol. Cell. Biol. 17: 2859–2865
Woerner SM, Gebert J, Yuan YP, Sutter C, Ridder R, Bork P, Doeberitz MVK . 2001 Int. J. Cancer 93: 12–19
Yamamoto H, Sawai H, Perucho M . 1997 Cancer Res. 57: 4420–4426
Zhang L, Yu J, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B . 2001 Cancer Res. 61: 3801–3805
Acknowledgements
This work was supported by grants from Korean Science and Engineering Fund through the Cancer Metastasis Research Center at Yonsei University, BK21 projects for Medical Sciences, Yonsei University, and Ministry of Commerce, Industry and Energy (N03-990-5411-01-1-3), Republic of Korea. Part of this work was presented at the annual meeting of the American Association for Cancer Research, San Francisco, April 6–10, 2002.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, NG., Rhee, H., Li, L. et al. Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability. Oncogene 21, 5081–5087 (2002). https://doi.org/10.1038/sj.onc.1205703
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205703
Keywords
This article is cited by
-
Whole exome analysis of patients in Japan with hearing loss reveals high heterogeneity among responsible and novel candidate genes
Orphanet Journal of Rare Diseases (2022)
-
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer
Journal of Translational Medicine (2020)
-
MARCKS regulates tonic and chronic active B cell receptor signaling
Leukemia (2019)
-
RCC2 is a novel p53 target in suppressing metastasis
Oncogene (2018)
-
Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer
Nature Communications (2017)